• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[信件:局部免疫调节加重的面部癣:两例病例报告]

[Letter: Tinea faciei exacerbated by topical immunomodulation: Two case reports].

作者信息

Ruiz-Villaverde Ricardo, Sanchez-Cano Daniel

出版信息

Dermatol Online J. 2010 Mar 15;16(3):14.

PMID:20233571
Abstract

Tinea faciei has commonly been included within the spectrum of tinea corporis. We report two pediatrics cases of tinea faciei that have been evaluated in our unit. Both were exacerbated by topical application of pimecrolimus cream. It is important to note the exacerbation of dermatophyte infection by pimecrolimus in addition to the better known exacerbation by topical corticosteroids.

摘要

面部癣通常被纳入体癣范畴。我们报告了在我们科室评估的两例儿童面部癣病例。两例均因外用吡美莫司乳膏而加重。除了外用糖皮质激素更常见的加重情况外,吡美莫司加重皮肤癣菌感染这一点也很重要。

相似文献

1
[Letter: Tinea faciei exacerbated by topical immunomodulation: Two case reports].[信件:局部免疫调节加重的面部癣:两例病例报告]
Dermatol Online J. 2010 Mar 15;16(3):14.
2
Cancer risk with topical pimecrolimus and tacrolimus.
Prescrire Int. 2005 Dec;14(80):223.
3
Pimecrolimus and tacrolimus: the US FDA public health advisory.
Skin Therapy Lett. 2005 May;10(4):1-3.
4
Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.使用吡美莫司、他克莫司和中至高效糖皮质激素进行局部治疗与淋巴瘤风险
Dermatology. 2009;219(1):7-21. doi: 10.1159/000209289. Epub 2009 Mar 17.
5
Tinea incognito.隐匿性癣菌病。
Clin Dermatol. 2010 Mar 4;28(2):137-9. doi: 10.1016/j.clindermatol.2009.12.011.
6
Association between exposure to topical tacrolimus or pimecrolimus and cancers.局部使用他克莫司或吡美莫司与癌症的关联性。
Ann Pharmacother. 2009 Dec;43(12):1956-63. doi: 10.1345/aph.1M278. Epub 2009 Nov 10.
7
Topical tacrolimus and pimecrolimus: future directions.外用他克莫司和吡美莫司:未来发展方向
Semin Cutan Med Surg. 2001 Dec;20(4):268-74. doi: 10.1053/sder.2001.29060.
8
Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.吡美莫司:新制剂。仿制药:风险太多,对特应性皮炎益处不足。
Prescrire Int. 2004 Dec;13(74):209-12.
9
Pimecrolimus induced tinea incognito masquerading as intertriginous psoriasis.吡美莫司诱发隐匿性癣,表现为擦烂性银屑病。
Mycoses. 2008 Jan;51(1):71-3. doi: 10.1111/j.1439-0507.2007.01436.x.
10
[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].[外用免疫调节剂,如他克莫司和吡美莫司,用于治疗特应性皮炎]
Ned Tijdschr Geneeskd. 2005 May 14;149(20):1096-100.